HIGHLIGHTS
- who: DNA methylation and colleagues from the Sichuan Cancer Hospital, China Beijing University of Technology, China have published the research: Recent progress in DNA methyltransferase inhibitors as anticancer agents, in the Journal: (JOURNAL)
- what: In the current review, the authors discussed the relationship between DNA methylation and tumor, the research progress, mechanism, and pharmacological properties of DNMTis with the purpose of promoting the development of DNMTis as an anti-tumor agent. It seems that hepatic toxicity is the main reason leading to the termination of Trisenox.
- how: A total of 20 patients with . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.